C-reactive protein to lymphocyte ratio as a new biomarker in predicting surgical site infection after posterior lumbar interbody fusion and instrumentation

被引:7
|
作者
Wu, Xiaofei [1 ]
Ma, Xun [1 ]
Zhu, Jian [1 ,2 ]
Chen, Chen [1 ]
机构
[1] Shanxi Med Univ, Shanxi Bethune Hosp, Hosp 3, Taiyuan, Peoples R China
[2] Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang, Peoples R China
来源
FRONTIERS IN SURGERY | 2022年 / 9卷
关键词
posterior lumbar interbody fusion; perioperative management; risk prediction tool; creative protein to lymphocyte count ratio (CLR); surgical site infection; DEEP WOUND-INFECTION; INFLAMMATION; CRP/ALBUMIN; DIAGNOSIS; OUTCOMES; MARKER; HEALTH; LEVEL; COUNT;
D O I
10.3389/fsurg.2022.910222
中图分类号
R61 [外科手术学];
学科分类号
摘要
PurposeThis study aims to evaluate the potential of C-reactive protein to lymphocyte count ratio (CLR) for the prediction of surgical site infection (SSI) following posterior lumbar interbody fusion (PLIF) and the instrumentation of lumbar degenerative diseases. MethodsIn this retrospective study, we considered patients with a lumbar degenerative disease diagnosis surgically treated by the instrumented PLIF procedure from 2015 to 2021. Patient data, including postoperative early SSI and other perioperative variables, were collected from their respective hospitalization electronic medical records. The receiver operator characteristic curve was constructed to determine the optimal cut-off value for CLR, and the ability to predict SSI was evaluated by the area under the curve (AUC). According to the cut-off value, patients were dichotomized with high- or low-CLR, and between-group differences were compared using univariate analysis. The independent impact of CLR on predicting SSI was investigated by multivariate logistics regression analysis. ResultsA total of 773 patients were included, with 26 (3.4%) developing an early SSI post-operation. The preoperative CLR was 11.1 +/- 26.1 (interquartile range, 0.4-7.5), and the optimal cut-off was 2.1, corresponding to a sensitivity of 0.856, a specificity of 0.643, and an AUC of 0.768 (95% CI, 0.737-0.797). CLR demonstrated a significantly improved prediction ability than did lymphocyte count (P = 0.021) and a similar ability to predict an infection as C-response protein (P = 0.444). Patients with a high CLR had a significantly higher SSI incidence than those with a low CLR (7.6% vs. 0.8%, P < 0.001). After adjustment for numerous confounding factors, CLR >= 2.1 was associated with an 11.16-fold increased risk of SSI, along with other significant variables, i.e., diabetes, preoperative waiting time, and surgical duration. ConclusionA high CLR exhibited an improved ability to predict incident SSI and was associated with a substantially increased risk of SSI following instrumented PLIF. After better-design studies verified this finding, CLR could potentially be a beneficial tool in surgical management.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Pre- and postoperative C-reactive protein as a risk factor of organ/space surgical site infection after hepatectomy
    Satoshi Yasuda
    Daisuke Hokuto
    Naoki Kamitani
    Yasuko Matsuo
    Shunsuke Doi
    Kenji Nakagawa
    Satoshi Nishiwada
    Minako Nagai
    Taichi Terai
    Masayuki Sho
    Langenbeck's Archives of Surgery, 408
  • [42] Osteopenia and Sarcopenia as Potential Risk Factors for Surgical Site Infection after Posterior Lumbar Fusion: A Retrospective Study
    Ruffilli, Alberto
    Manzetti, Marco
    Cerasoli, Tosca
    Barile, Francesca
    Viroli, Giovanni
    Traversari, Matteo
    Salamanna, Francesca
    Fini, Milena
    Faldini, Cesare
    MICROORGANISMS, 2022, 10 (10)
  • [43] Comment on "Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer''
    Zhang, Qu-xia
    Xu, Bin-bin
    Xue, Zhen
    ANNALS OF SURGERY, 2021, 274 (06) : E689 - E690
  • [44] Sequential Changes of Plasma C-Reactive Protein, Erythrocyte Sedimentation Rate and White Blood Cell Count in Spine Surgery : Comparison between Lumbar Open Discectomy and Posterior Lumbar Interbody Fusion
    Choi, Man Kyu
    Kim, Sung Bum
    Kim, Kee D.
    Ament, Jared D.
    JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2014, 56 (03) : 218 - 223
  • [45] The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis
    Jung Hyun Kwon
    Jeong Won Jang
    Young Woon Kim
    Sung Won Lee
    Soon Woo Nam
    Dongwook Jaegal
    Seungok Lee
    Si Hyun Bae
    BMC Gastroenterology, 15
  • [46] The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia
    Cilloniz, Catia
    Torres, Antoni
    Garcia-Vidal, Carolina
    Moreno-Garcia, Estela
    Amaro, Rosanel
    Soler, Nestor
    Angeles Marcos, M.
    Rico, Veronica
    Gabarrus, Albert
    Maria Nicolas, Josep
    Soriano, Alex
    ARCHIVOS DE BRONCONEUMOLOGIA, 2021, 57 : 79 - 82
  • [47] ASO Author Reflections: C-Reactive Protein/Lymphocyte Ratio as a Promising Marker for Predicting Survival in Pancreatic Cancer
    Fan, Zhiyao
    Luo, Guopei
    Gong, Yitao
    Liu, Chen
    Yu, Xianjun
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (10) : 4026 - 4027
  • [48] The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis
    Kwon, Jung Hyun
    Jang, Jeong Won
    Kim, Young Woon
    Lee, Sung Won
    Nam, Soon Woo
    Jaegal, Dongwook
    Lee, Seungok
    Bae, Si Hyun
    BMC GASTROENTEROLOGY, 2015, 15
  • [49] The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia
    Cilloniz Campos, Catia
    Peroni, Hector
    Domingo, Carles
    Munoz, Rebeca
    Lluis Bedini, Josep
    Soriano, Alex
    Torres, Antoni
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [50] ASO Author Reflections: C-Reactive Protein/Lymphocyte Ratio as a Promising Marker for Predicting Survival in Pancreatic Cancer
    Zhiyao Fan
    Guopei Luo
    Yitao Gong
    Chen Liu
    Xianjun Yu
    Annals of Surgical Oncology, 2020, 27 : 4026 - 4027